A Trusted Advisor to Financial Services Clients

WBB Securities provides financial services to biotechnology, medical device and healthcare companies.

WBB has raised more than $1 billion in placements, financial advisory and direct transactions for new and emerging companies.

Our extensive relationships with investors and media provide entrée to capital and media coverage.

WBB has been recognized as one of the most frequently mentioned news sources about biotechnology, medical device and healthcare.

Steve Brozak, our lead banker, was named a top Starmine analyst in biotechnology for 2010 and received The Wall Street Journal’s Best on the Street award for medical devices in 2011.

The following are some recent transactions by our investment banking team:

Athersys, Inc. – Financial Advisor — $9,000,000, March 2012

Athersys, Inc. – Financial Advisor — $12,100,000, January 2011

Geron Corporation – Co Manager — $93,500,000, December 2010

Neoprobe Corporation – Financial Consultant/Sole Placement Agent,  $16,450,000, December 2008-July 2009

Celldex Therapeutics, Inc. – Financial Advisor for Acquisition of Curagen, $94,500,000, May 2009

_{*WBB is governed by FINRA/NASD Rule 2711(k), which allows the same staff to perform analyst and investment activities in firms with limited transactions as manager or co-manager that produce below a specified threshold in gross investment banking revenue from those transactions.}